Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform

Mol Ther. 2024 Oct 2;32(10):3743-3745. doi: 10.1016/j.ymthe.2024.08.013. Epub 2024 Aug 22.
No abstract available

Publication types

  • Published Erratum